1-4 of 4
Markus Puhlmann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Selective activation of endothelium by tumor necrosis factor (TNF) sensitive but not TNF resistant melanoma cell lines

Monika L. Burness, Markus Puhlmann, David M. Weinreich, Ewa M. Turner, H. Richard Alexander, Jr.
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1139–11398.
Published: 01 April 2004
View articletitled, Selective activation of endothelium by tumor necrosis factor (TNF) sensitive but not TNF resistant melanoma cell lines
Journal Articles

Effect of Interleukin 1 Receptor Antagonist Gene Transduction on Human Melanoma Xenografts in Nude Mice

David M. Weinreich, Dina M. Elaraj, Markus Puhlmann, Stephen M. Hewitt, Nancy M. Carroll, Elizabeth D. Feldman, Ewa M. Turner, Paul J. Spiess, H. Richard Alexander
Journal: Cancer Research
Cancer Res (2003) 63 (18): 5957–5961.
Published: 01 October 2003
View articletitled, Effect of Interleukin 1 Receptor Antagonist Gene Transduction on Human Melanoma Xenografts in Nude Mice
Open the PDF for Effect of Interleukin 1 Receptor Antagonist Gene Transduction on Human Melanoma Xenografts in Nude Mice in another window
Journal Articles

Sensitization of Tumor Necrosis Factor α-resistant Human Melanoma by Tumor-specific in Vivo Transfer of the Gene Encoding Endothelial Monocyte-activating Polypeptide II Using Recombinant Vaccinia Virus

Michael F. X. Gnant, Adam C. Berger, James Huang, Markus Puhlmann, Peter C. Wu, Maria J. Merino, David L. Bartlett, H. Richard Alexander, Steven K. Libutti
Journal: Cancer Research
Cancer Res (1999) 59 (18): 4668–4674.
Published: 15 September 1999
View articletitled, Sensitization of Tumor Necrosis Factor α-resistant Human Melanoma by Tumor-specific in Vivo Transfer of the Gene Encoding Endothelial Monocyte-activating Polypeptide II Using Recombinant Vaccinia Virus
Open the PDF for Sensitization of Tumor Necrosis Factor α-resistant Human Melanoma by Tumor-specific in Vivo Transfer of the Gene Encoding Endothelial Monocyte-activating Polypeptide II Using Recombinant Vaccinia Virus in another window
Journal Articles

Systemic Administration of a Recombinant Vaccinia Virus Expressing the Cytosine Deaminase Gene and Subsequent Treatment with 5-Fluorocytosine Leads to Tumor-specific Gene Expression and Prolongation of Survival in Mice

Michael F. X. Gnant, Markus Puhlmann, H. Richard Alexander, Jr., David L. Bartlett
Journal: Cancer Research
Cancer Res (1999) 59 (14): 3396–3403.
Published: 15 July 1999
View articletitled, Systemic Administration of a Recombinant Vaccinia Virus Expressing the Cytosine Deaminase Gene and Subsequent Treatment with 5-Fluorocytosine Leads to Tumor-specific Gene Expression and Prolongation of Survival in Mice
Open the PDF for Systemic Administration of a Recombinant Vaccinia Virus Expressing the Cytosine Deaminase Gene and Subsequent Treatment with 5-Fluorocytosine Leads to Tumor-specific Gene Expression and Prolongation of Survival in Mice in another window